ES555668A0 - Un procedimiento para la preparacion de peptidos inmunogenicos sinteticos contra fmvd - Google Patents

Un procedimiento para la preparacion de peptidos inmunogenicos sinteticos contra fmvd

Info

Publication number
ES555668A0
ES555668A0 ES555668A ES555668A ES555668A0 ES 555668 A0 ES555668 A0 ES 555668A0 ES 555668 A ES555668 A ES 555668A ES 555668 A ES555668 A ES 555668A ES 555668 A0 ES555668 A0 ES 555668A0
Authority
ES
Spain
Prior art keywords
fmvd
procedure
preparation
immunogenic peptides
peptides against
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES555668A
Other languages
English (en)
Other versions
ES8707739A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of ES8707739A1 publication Critical patent/ES8707739A1/es
Publication of ES555668A0 publication Critical patent/ES555668A0/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/125Picornaviridae, e.g. calicivirus
    • A61K39/135Foot- and mouth-disease virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55566Emulsions, e.g. Freund's adjuvant, MF59
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/60Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031Proteins
    • A61K2039/6081Albumin; Keyhole limpet haemocyanin [KLH]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/32011Picornaviridae
    • C12N2770/32111Aphthovirus, e.g. footandmouth disease virus
    • C12N2770/32122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/32011Picornaviridae
    • C12N2770/32111Aphthovirus, e.g. footandmouth disease virus
    • C12N2770/32134Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/22Viral peptide or viral protein
    • Y10S930/222Foot and mouth disease related
ES555668A 1985-06-03 1986-06-03 Un procedimiento para la preparacion de peptidos inmunogenicos sinteticos contra fmvd Expired ES8707739A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US74078085A 1985-06-03 1985-06-03

Publications (2)

Publication Number Publication Date
ES8707739A1 ES8707739A1 (es) 1987-08-16
ES555668A0 true ES555668A0 (es) 1987-08-16

Family

ID=24978033

Family Applications (1)

Application Number Title Priority Date Filing Date
ES555668A Expired ES8707739A1 (es) 1985-06-03 1986-06-03 Un procedimiento para la preparacion de peptidos inmunogenicos sinteticos contra fmvd

Country Status (20)

Country Link
US (1) US4732971A (es)
EP (1) EP0204480B1 (es)
JP (1) JPS61282398A (es)
KR (1) KR890003944B1 (es)
CN (1) CN1019267B (es)
AT (1) AT396248B (es)
AU (1) AU595531B2 (es)
DE (1) DE3686095T2 (es)
DK (1) DK251286A (es)
EG (1) EG17812A (es)
ES (1) ES8707739A1 (es)
GR (1) GR861406B (es)
HK (1) HK101692A (es)
HU (1) HUT41050A (es)
IL (1) IL78913A (es)
NZ (1) NZ216362A (es)
PT (1) PT82651B (es)
SG (1) SG94792G (es)
SU (1) SU1662338A3 (es)
ZA (1) ZA863911B (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6024964A (en) * 1985-06-24 2000-02-15 Hoechst Aktiengesellschaft Membrane anchor/active compound conjugate, its preparation and its uses
US6074650A (en) * 1985-06-24 2000-06-13 Hoechst Aktiengesellschaft Membrane anchor/active compound conjugate, its preparation and its uses
US5864008A (en) * 1988-03-25 1999-01-26 James; Stephen Peptides derived from foot-and-mouth disease virus, pharmaceutical compositions, and methods for using the peptides
ZW6189A1 (en) * 1988-05-09 1990-05-09 Smithkline Beckman Corp Anti-aggregatory peptides
JP2527525B2 (ja) * 1992-03-27 1996-08-28 財團法人 牧岩生命工學研究所 新規な新症候出血熱ワクチンおよびその製造方法
CN1054544C (zh) * 1993-10-21 2000-07-19 复旦大学 家畜口蹄疫病毒多肽疫苗及其制备方法
US5538733A (en) * 1994-07-07 1996-07-23 Willmar Poultry Company, Inc. Method of priming an immune response in a one-day old animal
US6096863A (en) * 1996-08-23 2000-08-01 Regents Of The University Of Minnesota Self-assembling amphiphiles for construction of peptide secondary structures
DE19638044A1 (de) * 1996-09-18 1998-03-19 Bayer Ag Immunogene Peptide von Maul- und Klauenseuchen-Viren
US6048538A (en) * 1997-10-03 2000-04-11 United Biomedical, Inc. Peptides derived from the non-structural proteins of foot and mouth disease virus as diagnostic reagents
BR9908911A (pt) 1998-03-19 2001-10-02 Bristol Myers Squibb Co Sistema bifásico e processo de distribuição por liberação controlada de substâncias farmacêuticas de alta solubilidade
US6107021A (en) * 1998-06-20 2000-08-22 United Biomedical, Inc. Synthetic peptide vaccines for foot-and-mouth disease
US8058248B2 (en) * 2001-04-26 2011-11-15 The United States Of America As Represented By The Secretary Of Agriculture Foot and mouth disease virus vaccine comprising interferons
CN100342911C (zh) * 2004-01-13 2007-10-17 厦门大学 A、o型口蹄疫病毒双价dna疫苗及其制备方法
MX2011002836A (es) 2008-09-17 2011-04-28 Chiasma Inc Composiciones farmaceúticas y métodos de administración relacionados.
KR101942590B1 (ko) 2010-07-09 2019-01-25 비에이치브이 파르마, 인크. 레모글리플로진을 포함하는 짧은 반감기 약제용의 즉시/지연 조합 방출 전달 시스템
HUE051277T2 (hu) 2012-11-16 2021-03-01 United Biomedical Inc Szintetikus peptiden alapuló sürgõsségi vakcina ragadós száj- és körömfájás (FMD) ellen
CN114699518A (zh) 2015-01-16 2022-07-05 硕腾服务有限责任公司 口蹄疫疫苗
WO2016126830A1 (en) 2015-02-03 2016-08-11 Chiasma Inc. Method of treating diseases
CN107365367A (zh) * 2017-08-16 2017-11-21 山东省农业科学院奶牛研究中心 A型口蹄疫病毒vp1蛋白抗原表位基因多肽及其应用
US11141457B1 (en) 2020-12-28 2021-10-12 Amryt Endo, Inc. Oral octreotide therapy and contraceptive methods
WO2022221144A1 (en) * 2021-04-12 2022-10-20 University Of Washington Engineered peptides for αvβ6 integrin binding and related methods of use and synthesis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4140763A (en) * 1976-09-08 1979-02-20 The United States Of America As Represented By The Secretary Of Agriculture Vaccine for foot and mouth disease
AU547096B2 (en) * 1980-05-12 1985-10-03 Biogen N.V. Foot-and mouth disease viral antigens
EP0068693A3 (en) * 1981-06-16 1983-07-20 Genentech, Inc. Production of foot and mouth disease vaccine from microbially expressed antigens
ZA831854B (en) * 1982-03-26 1984-01-25 Biogen Nv Small peptides with the specificity of foot and mouth disease viral antigens
DE3382459D1 (de) 1982-04-14 1991-12-19 James L Bittle Kuenstliches pikornavirusantigen.

Also Published As

Publication number Publication date
DK251286D0 (da) 1986-05-29
EP0204480A2 (en) 1986-12-10
GR861406B (en) 1986-09-30
CN1019267B (zh) 1992-12-02
SU1662338A3 (ru) 1991-07-07
US4732971A (en) 1988-03-22
KR870000426A (ko) 1987-02-18
IL78913A0 (en) 1986-09-30
NZ216362A (en) 1989-04-26
DE3686095T2 (de) 1993-03-04
ES8707739A1 (es) 1987-08-16
EG17812A (en) 1990-08-30
SG94792G (en) 1992-12-04
EP0204480A3 (en) 1989-02-08
JPS61282398A (ja) 1986-12-12
EP0204480B1 (en) 1992-07-22
PT82651A (en) 1986-06-01
HUT41050A (en) 1987-03-30
ATA141786A (de) 1992-11-15
DE3686095D1 (de) 1992-08-27
CN86103718A (zh) 1987-02-04
KR890003944B1 (ko) 1989-10-13
IL78913A (en) 1991-01-31
AU5821286A (en) 1986-12-11
AU595531B2 (en) 1990-04-05
ZA863911B (en) 1988-01-27
HK101692A (en) 1992-12-24
PT82651B (pt) 1988-11-30
DK251286A (da) 1986-12-04
AT396248B (de) 1993-07-26

Similar Documents

Publication Publication Date Title
ES555668A0 (es) Un procedimiento para la preparacion de peptidos inmunogenicos sinteticos contra fmvd
ES557744A0 (es) Un procedimiento para la preparacion de nuevas piranopiridinas
ES551249A0 (es) Un procedimiento para la preparacion de peptidilaminodioles.
ES547840A0 (es) Un procedimiento para la preparacion de alquilsulfonamidofe-nilalquilaminas
ES556738A0 (es) Un procedimiento para la preparacion de nuevos piridazinaminas.
ES557387A0 (es) Un procedimiento para la preparacion de polipeptidos inmunogenicos
ES554983A0 (es) Un procedimiento para la preparacion de silileteres.
ES556057A0 (es) Un procedimiento para la preparacion de una composicion liofilizada de lipidos.
ES553415A0 (es) Un procedimiento para la preparacion de derivados de ariletanolamina.
ES557413A0 (es) Un procedimiento para la preparacion de un polialquenoilisocianato
ES554286A0 (es) Un procedimiento para la preparacion de nuevos derivados glicopepticos
ES557772A0 (es) Un procedimiento para la preparacion de epipodofilotoxina
ES540200A0 (es) Un procedimiento para la preparacion de acidos 7-amino-3-me-til sustituido-3-defem-4-carboxilicos
ES555155A0 (es) Un procedimiento para la preparacion de un material de calafateo de silicona.
ES554661A0 (es) Un procedimiento para la preparacion de un hidralizado proteico.
ES545298A0 (es) Un procedimiento para la preparacion de 4-amino-2-fenilqui- nolinas
ES557427A0 (es) Un procedimiento para la preparacion de tetrahidroimidazoquinazolinonas
ES553703A0 (es) Un procedimiento para la preparacion de vesiculas de fosfoliptidos.
MX162939B (es) Procedimiento mejorado para la preparacion de monoterbutiltolueno-diamina
ES553705A0 (es) Un procedimiento para la preparacion de una alcanoilanilida
ES557725A0 (es) Un procedimiento para la preparacion de aminoalquil secocantinas
ES554469A0 (es) Un procedimiento para la preparacion de derivados de mitomicina c
ES557435A0 (es) Un procedimiento para la preparacion de un hidrohaluro de oxazolindiona
ES542517A0 (es) Un procedimiento para la preparacion de monoalquil-polial- quilenpoliaminas
ES552185A0 (es) Un procedimiento para la preparacion de uretano

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970303